FDA Gives Nod to Gene Therapy for Hemophilia A

(MedPage Today) -- The FDA approved valoctocogene roxaparvovec (Roctavian) as the first gene therapy for the treatment of adults with severe hemophilia A, drug developer Biomarin announced on Thursday. Patients with severe disease are eligible...

https://www.medpagetoday.com/hematologyoncology/hemophilia/105278

Source: MedPage Today Hematology/Oncology - June 30, 2023 Category: Hematology Source Type: news